58 results
8-K
EX-99.1
KA
Kineta Inc
31 Mar 23
Kineta Reports Full Year 2022 Financial Results and Provides Corporate Update
4:03pm
of public health epidemics affecting countries or regions in which Kineta has operations or does business, such as the COVID-19 pandemic; the timing
8-K
EX-99.1
apvtqz1 r2p
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.4
xim7d32izc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.6
tukopr0wib
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.2
ew74fz0
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
cs61v2h45l
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
qpj 8l1pgh5w
10 Nov 22
Prospectus supplement
4:21pm
425
ubyugib3oliwrnt
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.2
udybzgsiskh
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm